Advertisement CryoCor files patent infringement lawsuits against CryoCath - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CryoCor files patent infringement lawsuits against CryoCath

CryoCor, a medical device company focused on the treatment of cardiac arrhythmias, has filed two patent infringement lawsuits against CryoCath Technologies, one in the US District Court of Delaware and one in Canada.

The lawsuits allege that CryoCath’s products infringe several patents related to CryoCor’s Cardiac Cryoablation System. CryoCor is an exclusive licensee of the patents, and is seeking monetary damages and injunctions in the US and Canada to prohibit further infringement.

Ed Brennan, president and CEO of CryoCor, said: “We believe that our exclusive license to these patents gives us broad coverage over key technologies that are critical in the field of cryoablation for cardiovascular applications. We have filed this lawsuit against CryoCath to enforce our intellectual property rights related to this critical segment of healthcare.”